70 related articles for article (PubMed ID: 3697317)
1. [Immunosuppressive properties of the serum of patients with lung cancer].
Plucińska M; Mierzwa W; Stadnicki M; Byszewska D; Rykiel B; Olechnowicz H; Roszkowski W; Rowińska-Zakrzewska E
Pneumonol Pol; 1987 Sep; 55(9):393-400. PubMed ID: 3697317
[No Abstract] [Full Text] [Related]
2. [Effect of sera from patients with lung cancer on proliferative properties of lymphocytes from healthy blood donors].
Plucińska M; Ponahajba A; Rogińska E; Rykiel B; Sakowicz A; Roszkowski W; Rowińska-Zakrzewska E
Pneumonol Pol; 1988 Jul; 56(7):302-8. PubMed ID: 3237473
[No Abstract] [Full Text] [Related]
3. Restoration of immunosuppression in lung cancer by normal sera.
Hadjipetrou-Kourounakis L; Manikou H; Tsougranis A
J Clin Lab Immunol; 1985 Mar; 16(3):149-53. PubMed ID: 4032453
[TBL] [Abstract][Full Text] [Related]
4. [Cyclic adenosine monophosphate content in the lymphocytes of cancer patients].
Bershteĭn LM; Revskoĭ SIu; Kovaleva IG; Dil'man VM
Eksp Onkol; 1985; 7(5):53-6. PubMed ID: 2998725
[TBL] [Abstract][Full Text] [Related]
5. [A study on immune response of regional lymph nodes in patients with lung cancer].
Sannoh K
Igaku Kenkyu; 1984 May; 54(6):695-709. PubMed ID: 6532067
[No Abstract] [Full Text] [Related]
6. Cellular immune competence of patients with lung cancer and other lung diseases. I. Analysis of peripheral blood lymphocyte subsets using monoclonal antibodies.
Fujiwara S; Akiyama M; Kobuke K; Ichimaru S; Takaishi M; Inamizu T; Kohno N; Takami S; Noumi K; Kawamoto M
Hiroshima J Med Sci; 1986 Sep; 35(3):227-36. PubMed ID: 3804783
[No Abstract] [Full Text] [Related]
7. [Studies on immune interferon production by peripheral blood lymphocytes in patients with lung cancer].
Kishimoto H; Shimokata K
Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Feb; 22(2):104-10. PubMed ID: 6433095
[No Abstract] [Full Text] [Related]
8. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
Hadjipetrou-Kourounakis L; Tsougranis A
Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
[TBL] [Abstract][Full Text] [Related]
9. Evidence for immune defects in breast and lung cancer patients.
Caras I; Grigorescu A; Stavaru C; Radu DL; Mogos I; Szegli G; Salageanu A
Cancer Immunol Immunother; 2004 Dec; 53(12):1146-52. PubMed ID: 15185014
[TBL] [Abstract][Full Text] [Related]
10. [Studies on immunosuppression in the patient with lung cancer: character and function of lymphocytes (author's transl)].
Inoue S
Hokkaido Igaku Zasshi; 1982 Jan; 57(1):87-100. PubMed ID: 7076110
[No Abstract] [Full Text] [Related]
11. [Activation of blood lymphocytes in lung cancer patients with polyclonal mitogens].
Oleĭnik EK; Bakhlaev IE; Ageenko AI
Vopr Onkol; 1997; 43(6):584-6. PubMed ID: 9479356
[TBL] [Abstract][Full Text] [Related]
12. In vitro mitogen-induced interferon production and lymphocyte blastogenesis in patients with lung cancer.
Suzuki S; Kumano N; Koinumaru S; Saijo Y; Oizumi K; Motomiya M; Konno K
Sci Rep Res Inst Tohoku Univ Med; 1986 Dec; 33(1-4):27-32. PubMed ID: 2442811
[No Abstract] [Full Text] [Related]
13. Regulation of lymphocyte responses in cancer patients. I. Study of cell-surface gangliosides by cholera toxin and their induction of impaired activation.
Tsuru S; Nomoto K; Aiso S; Ogata T; Zinnaka Y
Int Arch Allergy Appl Immunol; 1983; 71(1):88-92. PubMed ID: 6299969
[TBL] [Abstract][Full Text] [Related]
14. [Immunologic disorders associated with bronchopulmonary cancer: value of lymphoblastic transformation test].
Fréour P; Du Pasquier P; Nacef T; Chomy P; Bernadou M; Auriol JC; Wanou JJ
Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):549-58. PubMed ID: 5510322
[No Abstract] [Full Text] [Related]
15. Peripheral blood lymphocytes and their subpopulations in lung carcinoma.
Zółtowska A; Skokowski J; Mlekodaj S; Boj E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):649-53. PubMed ID: 6970027
[TBL] [Abstract][Full Text] [Related]
16. Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.
Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Yamaguchi K; Fukuhara S
J Cancer Res Clin Oncol; 2002 Jan; 128(1):29-36. PubMed ID: 11862469
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of measurement of immunosuppressive acidic protein (IAP) in lung cancer].
Kondo H; Seno N; Matsuo S; Otagaki S; Matsuki T; Hatayama T
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2163-70. PubMed ID: 6625623
[TBL] [Abstract][Full Text] [Related]
18. [Role of serum adenosine deaminase as an immune parameter of tuberculosis].
Kelbel C; Stumpf B; Schmidt W; Wetzel E; Lorenz J
Pneumologie; 1995 Dec; 49(12):684-8. PubMed ID: 8584540
[TBL] [Abstract][Full Text] [Related]
19. Myeloid and lymphoid dendritic cells and cytotoxic T lymphocytes in peripheral blood of non-small cell lung cancer patient--a pilot study.
Krawczyk P; Wojas K; Milanowski P; Roliński J
Adv Med Sci; 2006; 51():160-3. PubMed ID: 17357299
[TBL] [Abstract][Full Text] [Related]
20. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
